| Dilip Anmangandla, MD | |
|
28040 Dorothy Drive Suite 103, Agoura Hills, CA 91301 | |
| (818) 483-6334 | |
| (818) 483-6345 |
| Full Name | Dilip Anmangandla |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 28040 Dorothy Drive Suite 103, Agoura Hills, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942536495 | NPI | - | NPPES |
| 00A1195970 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | A119597 (California) | Primary |
| Entity Name | Inpatient Services Of California A Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609019215 PECOS PAC ID: 3274421532 Enrollment ID: O20040413000789 |
News Archive
In this UNFPA opinion piece, Babatunde Osotimehin, U.N. under-secretary-general and UNFPA executive director, and Sharon Camp, president and CEO of the Guttmacher Institute, reflect on last month's London Summit on Family Planning, where "leaders from 18 African countries made unprecedented commitments - financially and politically - to strengthen their family planning programs,"
To address the alarming injury rate in youth footballers in Sweden, the project Injury-Free Children and Adolescents: Towards Better Practice in Swedish Football (FIT project) seeks to fill in the knowledge gaps by bringing biomedical and social science together.
The integration of electronic patient-reported outcomes into the routine care of patients with metastatic cancer was associated with increased survival compared with usual care, according to a study published by JAMA.
Diakron Pharmaceuticals, Inc. announced today the signing of an exclusive license agreement for a novel investigational oral anticoagulant drug candidate discovered and developed through Phase I clinical trials by Merck & Co. Inc. Under the terms of the agreement, Diakron has the exclusive rights to develop, and, if approved, market and distribute the compound worldwide.
› Verified 6 days ago
| Entity Name | Hospitalist Medicine Physicians Of California Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184663965 PECOS PAC ID: 8426062027 Enrollment ID: O20060202000956 |
News Archive
In this UNFPA opinion piece, Babatunde Osotimehin, U.N. under-secretary-general and UNFPA executive director, and Sharon Camp, president and CEO of the Guttmacher Institute, reflect on last month's London Summit on Family Planning, where "leaders from 18 African countries made unprecedented commitments - financially and politically - to strengthen their family planning programs,"
To address the alarming injury rate in youth footballers in Sweden, the project Injury-Free Children and Adolescents: Towards Better Practice in Swedish Football (FIT project) seeks to fill in the knowledge gaps by bringing biomedical and social science together.
The integration of electronic patient-reported outcomes into the routine care of patients with metastatic cancer was associated with increased survival compared with usual care, according to a study published by JAMA.
Diakron Pharmaceuticals, Inc. announced today the signing of an exclusive license agreement for a novel investigational oral anticoagulant drug candidate discovered and developed through Phase I clinical trials by Merck & Co. Inc. Under the terms of the agreement, Diakron has the exclusive rights to develop, and, if approved, market and distribute the compound worldwide.
› Verified 6 days ago
| Entity Name | Tarzana Hospitalist Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255564944 PECOS PAC ID: 7810037868 Enrollment ID: O20091222000707 |
News Archive
In this UNFPA opinion piece, Babatunde Osotimehin, U.N. under-secretary-general and UNFPA executive director, and Sharon Camp, president and CEO of the Guttmacher Institute, reflect on last month's London Summit on Family Planning, where "leaders from 18 African countries made unprecedented commitments - financially and politically - to strengthen their family planning programs,"
To address the alarming injury rate in youth footballers in Sweden, the project Injury-Free Children and Adolescents: Towards Better Practice in Swedish Football (FIT project) seeks to fill in the knowledge gaps by bringing biomedical and social science together.
The integration of electronic patient-reported outcomes into the routine care of patients with metastatic cancer was associated with increased survival compared with usual care, according to a study published by JAMA.
Diakron Pharmaceuticals, Inc. announced today the signing of an exclusive license agreement for a novel investigational oral anticoagulant drug candidate discovered and developed through Phase I clinical trials by Merck & Co. Inc. Under the terms of the agreement, Diakron has the exclusive rights to develop, and, if approved, market and distribute the compound worldwide.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dilip Anmangandla, MD 28040 Dorothy Drive Suite 103, Agoura Hills, CA 91301 Ph: (818) 483-6334 | Dilip Anmangandla, MD 28040 Dorothy Drive Suite 103, Agoura Hills, CA 91301 Ph: (818) 483-6334 |
News Archive
In this UNFPA opinion piece, Babatunde Osotimehin, U.N. under-secretary-general and UNFPA executive director, and Sharon Camp, president and CEO of the Guttmacher Institute, reflect on last month's London Summit on Family Planning, where "leaders from 18 African countries made unprecedented commitments - financially and politically - to strengthen their family planning programs,"
To address the alarming injury rate in youth footballers in Sweden, the project Injury-Free Children and Adolescents: Towards Better Practice in Swedish Football (FIT project) seeks to fill in the knowledge gaps by bringing biomedical and social science together.
The integration of electronic patient-reported outcomes into the routine care of patients with metastatic cancer was associated with increased survival compared with usual care, according to a study published by JAMA.
Diakron Pharmaceuticals, Inc. announced today the signing of an exclusive license agreement for a novel investigational oral anticoagulant drug candidate discovered and developed through Phase I clinical trials by Merck & Co. Inc. Under the terms of the agreement, Diakron has the exclusive rights to develop, and, if approved, market and distribute the compound worldwide.
› Verified 6 days ago
Dr. Penny Jean Chong, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 29525 Canwood St, Suite 205, Agoura Hills, CA 91301 Phone: 818-781-5195 | |
Dr. Geoffrey A Booth, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 28632 Roadside Dr Ste 235, Agoura Hills, CA 91301 Phone: 310-801-0092 | |
Maria Jan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 29525 Canwood St Ste 300, Agoura Hills, CA 91301 Phone: 818-706-2477 Fax: 818-706-2368 | |
Dr. Jack M. Gindi, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 29525 Canwood St, Suite # 209, Agoura Hills, CA 91301 Phone: 818-706-7773 Fax: 818-706-0390 | |
Ruby C Simpkins, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 28240 Agoura Rd, Suite 201, Agoura Hills, CA 91301 Phone: 818-991-9800 Fax: 818-991-9814 | |
Dr. David Moskowitz, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 29525 Canwood St, Suite 300, Agoura Hills, CA 91301 Phone: 818-706-2477 Fax: 818-706-2368 |